Jit M - Search Results

1

COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.

Pearson CAB, Bozzani F, Procter SR, Davies NG, Huda M, Jensen HT, Keogh-Brown M, Khalid M, Sweeney S, Torres-Rueda S; CHiL COVID-19 Working Group; CMMID COVID-19 Working Group; Eggo RM, Vassall A, Jit M. Pearson CAB, et al. Among authors: jit m. PLoS Med. 2021 Oct 4;18(10):e1003815. doi: 10.1371/journal.pmed.1003815. eCollection 2021 Oct. PLoS Med. 2021. PMID: 34606520 Free PMC article.

2

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

Jit M, Edmunds WJ. Jit M, et al. Vaccine. 2007 May 16;25(20):3971-9. doi: 10.1016/j.vaccine.2007.02.070. Epub 2007 Mar 13. Vaccine. 2007. PMID: 17400341

3

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R. Jit M, et al. BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54. BMC Med. 2011. PMID: 21569406 Free PMC article.

4

The cost-effectiveness of rotavirus vaccination in Armenia.

Jit M, Yuzbashyan R, Sahakyan G, Avagyan T, Mosina L. Jit M, et al. Vaccine. 2011 Nov 8;29(48):9104-11. doi: 10.1016/j.vaccine.2011.08.127. Epub 2011 Sep 22. Vaccine. 2011. PMID: 21945959

5

Health and economic impact of the seasonal influenza vaccination programme in England.

Baguelin M, Jit M, Miller E, Edmunds WJ. Baguelin M, et al. Among authors: jit m. Vaccine. 2012 May 14;30(23):3459-62. doi: 10.1016/j.vaccine.2012.03.019. Epub 2012 Mar 22. Vaccine. 2012. PMID: 22446636

6

Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.

Jit M, Newall AT, Beutels P. Jit M, et al. Hum Vaccin Immunother. 2013 Apr;9(4):834-40. doi: 10.4161/hv.23637. Epub 2013 Jan 28. Hum Vaccin Immunother. 2013. PMID: 23357859 Free PMC article. Review.

7

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Jit M, Levin C, Brisson M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R. Jit M, et al. BMC Med. 2013 Jan 30;11:23. doi: 10.1186/1741-7015-11-23. BMC Med. 2013. PMID: 23363734 Free PMC article.

8

Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.

Quinn E, Jit M, Newall AT. Quinn E, et al. Among authors: jit m. Expert Rev Pharmacoecon Outcomes Res. 2014 Jun;14(3):425-35. doi: 10.1586/14737167.2014.908713. Epub 2014 Apr 16. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24734967 Review.

9

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.

Jit M, Brisson M, Portnoy A, Hutubessy R. Jit M, et al. Lancet Glob Health. 2014 Jul;2(7):e406-14. doi: 10.1016/S2214-109X(14)70237-2. Epub 2014 Jun 9. Lancet Glob Health. 2014. PMID: 25103394 Free article.

10

Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study.

Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, Lemieux-Mellouki P, Malagón T, Brisson M. Laprise JF, et al. Among authors: jit m. Vaccine. 2014 Oct 7;32(44):5845-53. doi: 10.1016/j.vaccine.2014.07.099. Epub 2014 Aug 12. Vaccine. 2014. PMID: 25131743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters